ORAI3 and neoplasm: The study reports an oncogenic switch in which cells, especially those exposed to tumor microenvironmental factors (here, arachidonic acid), change from homologous Orai1 complexes to more heterogeneous Orai1–Orai3 complexes by upregulating Orai3 expression.